TY  - JOUR

T1  - Better Reimbursement Decision-Making Based on Expected Cost-Effectiveness: Using Value of Information Decision Analysis to Improve The Design and Efficacy of A Phase Iii Program for Erlotinib

JO  - Value in Health

PY  - 2015/11/01

AU  - Mukherjee SC

AU  - Latimer N

AU  - Richards P

AU  - Nixon RM

AU  - Hall PS

ED  - 

DO  - DOI: 10.1016/j.jval.2015.09.2616

PB  - Elsevier BV

VL  - 18

IS  - 7

SP  - A700

EP  - A700

Y2  - 2025/03/13

ER  -